News

Planview Enhances Software Delivery with Plutora Acquisition

Planview Enhances Software Delivery with Plutora Acquisition

Planview's Strategic Acquisition of Plutora

Planview has made a major move by acquiring Plutora, a step aimed at enriching its product offerings. As a leader in Strategic Portfolio Management (SPM) and Digital Product Development (DPD), Planview is eager to harness Plutora's advanced Value Stream Management (VSM) solutions to bring great value to its customers.

Reasons for the Acquisition

This acquisition highlights the essential need for companies to make informed decisions based on accurate data, especially as they navigate the complexities of modern business and technology changes. Razat Gaurav, CEO of Planview, pointed out the advantage of this merger, which combines Plutora's expertise in measuring value streams with Planview's strong methods for connected work.

Improving Software Delivery Processes

Gaurav said, "When we combine Plutora’s capabilities with our wealth of experience, we’ll provide our customers with a full perspective on their software delivery lifecycle, delivering significant value." This partnership aims to drive organizations toward enhancing performance and speed in their software delivery results.

Emphasis on Flow Metrics

Dr. Mik Kersten, Chief Technology Officer at Planview, commented on the industry's transition from project-based methods to product-focused strategies, underscoring the rising importance of value stream management and flow in software delivery. By integrating Flow Metrics®, Planview intends to increase transparency throughout the software development pipeline, enabling teams to swiftly identify bottlenecks and refine their processes.

Plutora's Position in the Market

Established in 2011, Plutora has carved out a significant presence in the VSM solution market by effectively helping organizations streamline their software development processes. Their method includes capturing, visualizing, and analyzing critical metrics to ensure that software development aligns with broader business objectives.

Alignment in Business Objectives

Dalibor Siroky, Co-Founder and CEO of Plutora, shared a mutual vision with Planview: enabling businesses to achieve significant results through improved visibility and agility. This merger promises customers a wider range of tools and insights, helping them manage their software projects more effectively.

Continuity and Future Prospects

The acquisition ensures that existing Plutora customers will have a seamless transition as the Plutora team joins Planview while retaining service quality. Customers will continue to access their preferred Work, Agile, and Release Management solutions, now enriched with Plutora's top-notch offerings in areas like Release Management and Deployment Planning.

Upcoming Events and Initiatives

This acquisition aligns with the upcoming launch of Planview's first Project to Product Summit, which will be held soon. This virtual event aims to cover essential practices related to digital product delivery and to illustrate frameworks for transitioning from project-focused methods to product-centric strategies. Attending this summit is an excellent opportunity for organizations to enhance their understanding of effective digital transformation.

About Planview

Planview is recognized as a top platform for Strategic Portfolio Management (SPM) and Digital Product Development (DPD). By supporting companies through extensive digital transformation efforts, Planview helps organizations improve their time-to-market efficiency, unlock resources, and ensure the optimal delivery of strategic initiatives. With a strong customer base of over 4,500 and 2.7 million active users worldwide, including 59 Fortune 100 companies, Planview, headquartered in Austin, Texas, employs more than 1,400 people globally.

Frequently Asked Questions

What prompted Planview's acquisition of Plutora?

Planview's acquisition of Plutora was driven by a shared goal of enhancing value stream management and improving software delivery processes.

How does this acquisition benefit Planview's customers?

This acquisition allows Planview to offer improved visibility and control over the software delivery lifecycle, enhancing efficiency and decision-making capabilities for its customers.

What core strengths does Plutora bring to Planview?

Plutora provides industry-leading solutions in value stream management and software delivery, which will complement Planview's existing product offerings.

What is the significance of the Project to Product Summit?

The Project to Product Summit serves as a platform for organizations to learn about methods and practices necessary for thriving in digital product delivery.

How will the integration of Plutora affect existing customers?

Existing Plutora customers will experience continuity with their services while gaining access to enhanced tools through Planview's offerings.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 19

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 14

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 14

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 16

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 14

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 15

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading

Top 5 Most Recently Viewed Articles

China's Strategic Response to US Tariff Increases Affects Companies

Updated Category News Views 329

China's Response to Increased US Tariffs China has taken a strong stand against recent tariff increases implemented by the U.S., positioning itself as a formidable player in international trade. This reaction includes reciprocal tariffs on a range of American products, sanctions on U.S. companies, and plans to address these issues through the World Trade Organization....

Continue Reading
Clearwater Living Achieves Energy Star Certification for 2025

Updated Category News Views 189

Clearwater Living Earns Energy Star Certification Clearwater Living, a reputable real estate and property management company, has made significant strides in energy efficiency. The company announced that three of its Arizona communities have been awarded the prestigious Energy Star certification, recognizing their superior performance in energy management. This honor...

Continue Reading
e.l.f. Beauty Champions Empowerment with Amanda Nguyen Partnership

Updated Category News Views 493

e.l.f. Beauty Celebrates Women's Empowerment with Amanda Nguyen e.l.f. Beauty (NYSE: ELF) has made an exciting announcement about its collaboration with Amanda Nguyen, a prominent activist, Nobel Peace Prize nominee, and astronaut. This partnership aims to combine the magic of beauty with the powerful message of empowerment, demonstrating e.l.f.'s dedication to making...

Continue Reading
Lifeway Foods and Danone Forge New Path with Cooperation Agreement

Updated Category News Views 331

Lifeway Foods and Danone Collaboration Announcement Lifeway Foods, Inc. (NASDAQ: LWAY) has taken a significant step forward by entering into a Cooperation Agreement with Danone North America PBC. This strategic collaboration aims to bolster the organizational structure of Lifeway while ensuring stability in the company’s governance. Board Refreshment Strategy As...

Continue Reading
Rémy Cointreau Faces Sales Challenges Amid Revised Forecasts

Updated Category News Views 263

Rémy Cointreau's Recent Sales Decline Rémy Cointreau's shares recently experienced a notable decline, reflecting the company's challenging financial landscape. Following a recent forecast cut, the company reported disappointing sales results for the second quarter, culminating in a sense of urgency among analysts and investors alike. Revised Outlook and Sales...

Continue Reading